These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25344194)

  • 1. [Research advances in the role of fecal calprotectin in intestinal development and diseases among children].
    Li F; Sheng XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1064-9. PubMed ID: 25344194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of fecal calprotectin determination in pediatric intestinal diseases.
    Rosso C; Caviglia GP; Pellicano R
    Minerva Pediatr; 2016 Dec; 68(6):478-486. PubMed ID: 27668453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of calprotectin in pediatric disease.
    Vaos G; Kostakis ID; Zavras N; Chatzemichael A
    Biomed Res Int; 2013; 2013():542363. PubMed ID: 24175291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fecal calprotectin in preterm infants with necrotizing enterocolitis.
    Aydemir G; Cekmez F; Tanju IA; Canpolat FE; Genc FA; Yildirim S; Tunc T; Sarici SU
    Clin Lab; 2012; 58(7-8):841-4. PubMed ID: 22997988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pediatrics. Fecal calprotectin in children: use and interpretation].
    Ezri J; Nydegger A
    Rev Med Suisse; 2011 Jan; 7(277):69-70. PubMed ID: 21309180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis.
    Østgård RD; Deleuran BW; Dam MY; Hansen IT; Jurik AG; Glerup H
    Scand J Rheumatol; 2018 Jan; 47(1):48-55. PubMed ID: 28649913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
    Chen CC; Huang JL; Chang CJ; Kong MS
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Faecal calprotectin in inflammatory bowel diseases: review].
    Kallel L; Fekih M; Boubaker J; Filali A
    Tunis Med; 2011 May; 89(5):425-9. PubMed ID: 21557177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis.
    Selimoğlu MA; Temel I; Yıldırım Ç; Özyaln F; Aktaş M; Karabiber H
    Pediatr Crit Care Med; 2012 Jul; 13(4):452-4. PubMed ID: 22079952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fecal calprotectin in complex diagnostics of intestinal diseases].
    Livzan MA; Dolgikh TI; Lialiukova EA
    Eksp Klin Gastroenterol; 2013; (12):83-6. PubMed ID: 24933995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin concentrations in alcoholic patients: a longitudinal study.
    Montalto M; Gallo A; Ferrulli A; Visca D; Campobasso E; Cardone S; D'Onofrio F; Santoro L; Covino M; Mirijello A; Leggio L; Gasbarrini G; Addolorato G
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):76-80. PubMed ID: 21030869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of calprotectin in faeces].
    Jahnsen J; Røseth AG; Aadland E
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):743-5. PubMed ID: 19373299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Faecal calprotectin in inflammatory bowel disease].
    Sipponen T; Kolho KL
    Duodecim; 2011; 127(24):2631-7. PubMed ID: 22320105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T; Kolho KL
    Scand J Gastroenterol; 2010 Aug; 45(7-8):872-7. PubMed ID: 20377469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis.
    Reisinger KW; Van der Zee DC; Brouwers HA; Kramer BW; van Heurn LW; Buurman WA; Derikx JP
    J Pediatr Surg; 2012 Sep; 47(9):1640-5. PubMed ID: 22974599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis.
    Carroll D; Corfield A; Spicer R; Cairns P
    Lancet; 2003 Jan; 361(9354):310-1. PubMed ID: 12559868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report].
    Krzesiek E; Iwańczak B
    Pol Merkur Lekarski; 2010 Oct; 29(172):241-6. PubMed ID: 21207640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.